CapitalG invested in the no-code app software provider at a $2.1bn valuation more than five times higher than it was 18 months ago.

The Standard Chartered-backed owner of digital wallet Momo will use the funding to launch its own strategic investment subsidiary.

Genomic drug developer Tessera Therapeutics raised $230m in a round co-led by SoftBank Vision Fund 2 as it works on its gene writing technology.

Corning and SoftBank-backed dynamic glass producer View's previously announced reverse merger will be boosted by $200m from Singapore's sovereign wealth fund.

GV helped longtime portfolio company and database platform developer Cockroach Labs take its total funding to $355m at a $2bn valuation.

The Access Industries and Volkswagen-backed business transport platform developer has added $15m to a round valuing it at $1.5bn.

The Workday, Salesforce and ServiceNow-backed workflow automation software provider boosted its valuation to $1.7bn and its overall funding to over $220m.

Temporary staffing portal Jobandtalent has added $108m to its latest round from investors including Seek to take its total funding to roughly $290m.

The Commerzbank-backed financial services software provider's valuation now tops $2bn, TCV having led its latest round.

Lilly Asia Ventures, a regional corporate venturing subsidiary of pharmaceutical firm Eli Lilly, reinvested in a round set to accelerate development of Abbisko's cancer-focused drug candidates.